Literature DB >> 16148006

ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.

Céline Tárrega1, Pablo Ríos, Rocío Cejudo-Marín, Carmen Blanco-Aparicio, Lieke van den Berk, Jan Schepens, Wiljan Hendriks, Lydia Tabernero, Rafael Pulido.   

Abstract

The two regulatory residues that control the enzymatic activity of the mitogen-activated protein (MAP) kinase ERK2 are phosphorylated by the unique MAP kinase kinases MEK1/2 and dephosphorylated by several tyrosine-specific and dual specificity protein phosphatases. Selective docking interactions facilitate these phosphorylation and dephosphorylation events, controlling the specificity and duration of the MAP kinase activation-inactivation cycles. We have analyzed the contribution of specific residues of ERK2 in the physical and functional interaction with the ERK2 phosphatase inactivators PTP-SL and MKP-3 and with its activator MEK1. Single mutations in ERK2 that abrogated the dephosphorylation by endogenous tyrosine phosphatases from HEK293 cells still allowed efficient phosphorylation by endogenous MEK1/2. Discrete ERK2 mutations at the ERK2 docking groove differentially affected binding and inactivation by PTP-SL and MKP-3. Remarkably, the cytosolic retention of ERK2 by its activator MEK1 was not affected by any of the analyzed ERK2 single amino acid substitutions. A chimeric MEK1 protein, containing the kinase interaction motif of PTP-SL, bound tightly to ERK2 through its docking groove and behaved as a gain-of-function MAP kinase kinase that hyperactivated ERK2. Our results provide evidence that the ERK2 docking groove is more restrictive and selective for its tyrosine phosphatase inactivators than for MEK1/2 and indicate that distinct ERK2 residues modulate the docking interactions with activating and inactivating effectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148006     DOI: 10.1074/jbc.M504366200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Targeting ERK beyond the boundaries of the kinase active site in melanoma.

Authors:  Rachel M Sammons; Ranajeet Ghose; Kenneth Y Tsai; Kevin N Dalby
Journal:  Mol Carcinog       Date:  2019-06-12       Impact factor: 4.784

2.  Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.

Authors:  Caroline E Nunes-Xavier; Céline Tárrega; Rocío Cejudo-Marín; Jeroen Frijhoff; Asa Sandin; Arne Ostman; Rafael Pulido
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

3.  The interaction of p38 with its upstream kinase MKK6.

Authors:  Ganesan Senthil Kumar; Rebecca Page; Wolfgang Peti
Journal:  Protein Sci       Date:  2021-02-16       Impact factor: 6.725

Review 4.  Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.

Authors:  Christopher J Caunt; Stephen M Keyse
Journal:  FEBS J       Date:  2012-08-28       Impact factor: 5.542

5.  Phosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways.

Authors:  Robin J Dickinson; Laurent Delavaine; Rocío Cejudo-Marín; Graeme Stewart; Christopher J Staples; Mark P Didmon; Antonio Garcia Trinidad; Andrés Alonso; Rafael Pulido; Stephen M Keyse
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

6.  Interface analysis of the complex between ERK2 and PTP-SL.

Authors:  Mihaela C Balasu; Laurentiu N Spiridon; Simona Miron; Constantin T Craescu; Axel J Scheidig; Andrei-Jose Petrescu; Stefan E Szedlacsek
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

7.  Differential Role of Threonine and Tyrosine Phosphorylation in the Activation and Activity of the Yeast MAPK Slt2.

Authors:  Gema González-Rubio; Ángela Sellers-Moya; Humberto Martín; María Molina
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

8.  Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications.

Authors:  Sinnie Sin Man Ng; Andrew Li; George N Pavlakis; Keiko Ozato; Tomoshige Kino
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

9.  Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.

Authors:  Muhammad Khairi Ahmad; Nur Ainina Abdollah; Nurul Husna Shafie; Narazah Mohd Yusof; Siti Razila Abdul Razak
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.